Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/1999
03/23/1999US5886039 Administering to uretha a lipophilic active agent selected from the group consisting of vasoactive prostaglandins
03/23/1999US5886036 Treating hiv infections
03/23/1999US5886026 Anti-angiogenic compositions and methods of use
03/23/1999US5886003 Administering 5-ht2 antagonists
03/23/1999US5885974 Decreases the dosage of bioactive agent necessary, when administered to a patient with abnormal cell metabolism, to correct the abnormal cell metabolism and promote the resumption of normal cell metabolism
03/23/1999US5885805 gbpA
03/23/1999US5885800 DNA encoding tumor necrosis related receptor, TR4
03/23/1999US5885601 Delivering antibiotic directly to the uterine cavity or fallopian tube of the female in an amount effective to cause sterilization
03/23/1999US5885592 Methods and pharmaceutical compositions for oral delivery of molecular iodine
03/23/1999US5885572 Administering polypeptide or active fragment to treat bacterial infections
03/23/1999US5885241 Treatment with an electrically-activated substance
03/23/1999CA2127462C Treatment for asthma
03/23/1999CA2072624C Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
03/22/1999CA2244237A1 A human lig-1 homolog (hlig-1)
03/18/1999WO1999013329A1 Methods of identifying molecules that home to angiogenic vasculature in tumors
03/18/1999WO1999013095A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999WO1999013078A1 Cysteine rich receptors-train
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999012968A2 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999WO1999012965A2 April- a novel protein with growth effects
03/18/1999WO1999012964A2 Kay - a novel immune system protein
03/18/1999WO1999012963A2 Cysteine rich receptors: trail
03/18/1999WO1999012961A1 Estrogen receptor
03/18/1999WO1999012640A1 Coated particles, methods of making and using
03/18/1999WO1999012567A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999WO1999012562A1 Synthetic antigens for cd1-restricted immune responses
03/18/1999WO1999012559A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999WO1999012557A1 Novel prokaryotic polynucleotides, polypeptides and their uses
03/18/1999WO1999012554A1 Chemical supplementation of bone
03/18/1999WO1999012551A1 Method of increasing bone volume using non-naturally-occurring fp selective agonists
03/18/1999WO1999012550A1 Method of increasing bone volume
03/18/1999WO1999012537A1 Analgesic compositions comprising anti-epileptic compounds and methods of using same
03/18/1999WO1999012533A1 A method of modulating cellular activity
03/18/1999WO1999012531A2 Hormonal contraceptive
03/18/1999WO1999012529A2 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
03/18/1999WO1999012524A1 MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs)
03/18/1999WO1999012523A1 Modulation of drug loading in multivesicular liposomes
03/18/1999WO1999012521A1 New foam-forming pharmaceutical composition
03/18/1999WO1999000140A3 Accelerating animal hoof growth with somatotropin
03/18/1999WO1998058629A3 Preparation of pharmaceutical compositions
03/18/1999WO1998057987A3 Irs-p53h, human insulin receptor tyrosine kinase substrate
03/18/1999WO1998055510A3 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
03/18/1999DE19739916A1 Mittel zur hormonalen Kontrazeption Means for hormonal contraception
03/18/1999DE19737224A1 Pharmaceutical preparation for cardiovascular treatment
03/18/1999CA2304108A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999CA2303800A1 Method of increasing bone volume using non-naturally-occurring fp selective agonists
03/18/1999CA2303799A1 Method of increasing bone volume
03/18/1999CA2303615A1 April- a novel protein with growth effects
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2303424A1 Kay - a novel immune system protein
03/18/1999CA2303422A1 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999CA2303396A1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999CA2303347A1 Chemical supplementation of bone
03/18/1999CA2302710A1 New foam-forming pharmaceutical composition
03/18/1999CA2302155A1 Synthetic antigens for cd1-restricted immune responses
03/18/1999CA2301979A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999CA2301883A1 Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
03/18/1999CA2301173A1 Cysteine rich receptors-train
03/18/1999CA2244323A1 Novel gapdh
03/17/1999EP0902087A2 Histidine kinase
03/17/1999EP0901788A2 Use of inhibitors of the sodium hydrogen exchange in the manufacture of a medicament
03/17/1999EP0901503A1 Synthetic glucagon binding proteins
03/17/1999EP0901379A2 Type-2 chemokine binding proteins and methods of use therefor
03/17/1999EP0901378A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
03/17/1999EP0901376A1 Malatonin in combination with analgesics
03/17/1999EP0901375A1 Dhea combination therapy
03/17/1999EP0901370A1 Stimulation of immune response with low doses of il-2
03/17/1999EP0901368A1 Dermal penetration enhancers and drug delivery systems involving same
03/17/1999EP0831858A4 Intrauterine chemical necrosing method and composition
03/17/1999EP0819003A4 A method for the treatment of macular degeneration
03/17/1999EP0616536B1 Use of decorin or biglycan for the manufacture of a medicament in the treatment of diabetes-associated pathology
03/17/1999EP0565634B1 Angiotensin ii receptor blocking compositions
03/17/1999CN1211255A Ob receptor and method of diagnosing and treating weight
03/17/1999CN1211193A Contraceptive release systems with antibacterial and/or antiviral effect
03/17/1999CN1211189A Urogenital and intestinal disorder compositions comprising a substrance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
03/17/1999CN1211184A Use of leukotriene B4 or its analogues as antiviral and antineoplastic agents
03/17/1999CN1211180A Method of treatment with compounds having RAG 'alpha' receptor specific or selective activity
03/17/1999CN1211178A Method of inhibiting photoaging of skin
03/17/1999CA2244330A1 Novel histidine kinase
03/16/1999US5883239 aroA
03/16/1999US5883137 Compositions and methods for the control of smoking
03/16/1999US5883128 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883119 Triterpene derivatives with immunosuppressant activity
03/16/1999US5883109 Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
03/16/1999US5883079 Method for inhibiting H. pylori infection in mammalian tissue
03/16/1999US5883074 Potentiators of antibacterial agents
03/16/1999US5882944 Methods for G protein coupled receptor activity screening
03/16/1999US5882910 Lipid kinase
03/16/1999US5882897 yitJ
03/16/1999US5882892 Polypeptides and dna(rna) encoding and screening for bactericides
03/16/1999US5882891 Polynucleotide segments
03/16/1999US5882889 Response regulator in a two component signal transduction system
03/16/1999US5882885 Polypeptides and polynucleotides
03/16/1999US5882860 Hybridization of nucleic acid derived from cell with polynucleotide; genetic engineering; suppressing gene expression
03/16/1999US5882671 Using an agonist which acts at negatively coupled camp-linked metabotropic glutamate receptors
03/16/1999US5882328 Method to prevent transplant rejection
03/16/1999CA2164689C Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis
03/16/1999CA2158108C Compositions containing sertraline and a 5-ht1d receptor agonist or antagonist
03/16/1999CA2108963C Compositions and methods for therapy and prevention of cancer, aids and anemia
1 ... 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 ... 1151